Stragenics (ASAB) 10-Q 20 May 15 2015 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Mar. 31, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	STRAGENICS, INC.
Entity Central Index Key	1456993
Amendment Flag	FALSE
Current Fiscal Year End Date	-19
Document Type	10-Q
Document Period End Date	31-Mar-15
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding	99,845,602

Consolidated_Balance_Sheets_Un

Consolidated Balance Sheets (Unaudited) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Current Assets
Cash and equivalents	$5,755	$104
Prepaid expenses	25,688
Total Current Assets	31,443	104
Other Current Assets
Intellectual Property, (less accumulated amortization of $11,892)	163,108	172,027
Total Other Assets	163,108	172,027
TOTAL ASSETS	194,551	172,131
Current Liabilities
Accounts payable and accrued expenses	128,725	139,525
Accrued interest	267,546	242,917
Convertible notes payable, net of discount of $84,976 (2014 - $0)	1,462,456	1,446,632
Derivative liability	1,040,232	372,286
Advances from officer	12,720	15,720
Loans payable	521,116	531,916
Advances from shareholders	6,500	6,000
Total Liabilities	3,439,295	2,754,996
Stockholders' Deficit
Preferred Stock Authorized: 100,000,000 preferred shares. No shares issued and outstanding at March 31, 2015 and December 31, 2014
Common Stock, 400,000,000 shares of common stock with par value of $.0001; Issued 99,845,602 shares of common stock issued and outstanding at March 31, 2015 and (98,226,850) - December 31, 2014	9,985	9,823
Additional paid in capital	635,153	516,984
Accumulated other comprehensive loss	835	835
Accumulated deficit	-3,890,717	-3,110,507
Total Stockholders' Deficit	-3,244,744	-2,582,865
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$194,551	$172,131

Consolidated_Balance_Sheets_Un1

Consolidated Balance Sheets (Unaudited) (Parenthetical) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Statement of Financial Position [Abstract]
Net of accumulated amortization	$11,892
Net of discount, Convertible notes payable	$84,976	$0
Preferred stock, Shares authorized	100,000,000	100,000,000
Preferred stock, Shares issued
Preferred stock, Shares outstanding
Common stock, Shares authorized	400,000,000
Common stock, Par value	$0.00
Common stock, Shares issued	99,845,602	98,226,850
Common stock, Shares outstanding	99,845,602	98,226,850

Consolidated_Statements_of_Ope

Consolidated Statements of Operations and Other Comprehensive Income (Loss) (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Income Statement [Abstract]
REVENUES
EXPENSES
Professional fees	10,000	4,010
Consulting fees	11,163
Compensation	15,000
Office expense	1,208	1,179
Filing and registration	840	1,321
Amortization of website	8,919
General and administrative	8,233
TOTAL EXPENSES	55,363	6,510
LOSS FROM OPERATIONS	-55,363	-6,510
OTHER INCOME (EXPENSES)
Other income	1,082
Interest expense	-24,629	-13,077
Commitment fee	-118,330
Amortization of debt discount	-25,023	-1,302
Derivative expense	-167,790
Change in fair market value of derivative liability	-390,157	-267,313
TOTAL OTHER INCOME (EXPENSE)	-724,847	-281,692
LOSS BEFORE PROVISION FOR INCOME TAXES	-780,210	-288,202
PROVISION FOR INCOME TAXES
NET INCOME LOSS	-780,210	-288,202
OTHER COMPREHENSIVE LOSS
Foreign currency translation adjustments
TOTAL COMPREHENSIVE LOSS	($780,211)	($288,202)
NET LOSS PER SHARE: BASIC AND DILUTED	($0.01)	$0
TOTAL COMPREHENSIVE LOSS PER SHARE: BASIC AND DILUTED	($0.01)	$0
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC AND DILUTED	99,647,755	89,005,250

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss for the period	($780,210)	($288,202)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization	8,919
Comittment fee - stock-based	118,330
Amortization of debt discount	25,023	1,302
Derivative expense	167,790
Change in fair market value of derivative liability	390,157	267,313
Changes in assets and liabilities:
Increase in prepaid expenses	-25,688
Increase (decrease) in accounts payable and accrued expenses	-10,799	-7,500
Increase in accrued interest	24,629	13,077
Net Cash Used in Operating Activities	-81,849	-14,010
CASH FLOWS FROM FINANCING ACTIVITIES
Bank overdraft		-409
Proceeds (Repayment) from promissory notes	-19,500	15,000
Proceeds from convertible notes payable	110,000
Advances (Repayment) from shareholder	-3,000	5,100
Net Cash Provided by Financing Activities	87,500	19,691
Exchange rate effect on cash
NET INCREASE IN CASH	5,651	5,681
Cash and equivalents, beginning of period	104
Cash and equivalents, end of period	5,755	5,681
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for interest
Cash paid for income taxes

Summary_of_Significant_Account

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2015
Summary of Significant Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Nature of Business
	Stragenics, Inc., formerly known as Allerayde SAB, Inc. (the “Company” or “Stragenics”) was incorporated under the laws of the State of Florida on January 15, 2009. On February 23, 2010, the Company changed its name to Resource Exchange of America Corp. Effective April 30, 2013, the Company changed its name to Allerayde SAB, Inc. Effective April 28, 2014, the Company changed its name to Stragenics, Inc.
	The Company’s prior business was a mobile enterprise software company aimed at improving productivity of field service organizations. Upon completion of the acquisition of assets from UTP Holdings, LLC on February 22, 2010, the Company adopted the business of UTP Holdings, LLC. The Company was then engaged in the business of recycling ferrous and nonferrous metals to customers in the United States and abroad.
	On March 21, 2013, the Company entered into a Share Exchange Agreement with Allerayde SAB Limited. (“Allerayde”) and Mike Rhodes, the sole member of Allerayde (the “Allerayde Stockholder”) (the “Share Exchange Agreement”). This share exchange transaction constituted a reverse merger and a recapitalization of Stragenics (formerly Allerayde).  In conjunction with this reverse merger, the historical accounts of Stragenics become the historical accounts of Resource Exchange of America Corp for accounting purposes. The Company was then engaged in the business of developing and manufacturing allergy management products in the United Kingdom and other countries such as the U.S. and Canada.
	On March 4, 2014, the Company underwent a change of control and entered into a Termination Agreement (the “Agreement”), whereby Allerayde SAB, Ltd, the Company’s subsidiary reverted to former management effective December 1, 2014, thereby reverting the subsidiary back to former management.
	On December 1, 2014, the Company acquired BakedAmerican.com, and began new operations as an internet-based, social media, marketing and development company.
	Accounting Basis
	The Company uses the accrual basis of accounting and accounting principles generally accepted in the United States of America (“GAAP” accounting).  The Company has adopted a December 31 fiscal year end.
	Cash and Cash Equivalents
	Stragenics considers all highly liquid investments with maturities of three months or less to be cash equivalents. At March 31, 2015 and December 31, 2014, respectively, the Company had $5,755 and $104 of cash, respectively.
	Fair Value Measurement
	FASB ASC 820, “Fair Value Measurements” defines fair value, establishes a framework for measuring fair value under generally accepted accounting principles and prescribes disclosures about fair value measurements.
	As defined in ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. The Company classifies fair value balances based on the observability of those inputs. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement).
	The three levels of the fair value hierarchy defined by ASC 820 are as follows:
	Level 1 - Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.
	Level 2 - Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date. Level 2 includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.
	Level 3 - Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.
	The valuation techniques that may be used to measure fair value are as follows:
	Market approach - Uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities.
	Income approach - Uses valuation techniques to convert future amounts to a single present amount based on current market expectations about those future amounts, including present value techniques, option-pricing models and excess earnings method.
	Cost approach - Based on the amount that currently would be required to replace the service capacity of an asset (replacement cost).
	The carrying value of the Company’s borrowings is a reasonable estimate of its fair value as borrowings under the Company’s credit facility have variable rates that reflect currently available terms and conditions for similar debt.
	The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment, and may affect the valuation of fair value assets and liabilities and their placement within the fair value hierarchy levels.
	The following table sets forth by level within the fair value hierarchy the Company’s financial assets and liabilities that were accounted for at fair value as of March 31, 2105 and December 31, 2014. As required by FASB ASC 820, financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.
	31-Mar-15	Level I		Level II		Level III		Total
	Derivative liability	$	-	$	1,040,232	$	-	$	1,040,232
	Total liabilities	$	-	$	3,439,295	$	-	$	3,439,295
	31-Dec-14	Level I		Level II		Level III		Total
	Derivative liability	$	-	$	372,286	$	-	$	372,286
	Total liabilities	$	-	$	2,754,996	$	-	$	2,754,996
	In addition, the FASB issued, “The Fair Value Option for Financial Assets and Financial Liabilities. This guidance expands opportunities to use fair value measurements in financial reporting and permits entities to choose to measure many financial instruments and certain other items at fair value. The Company did not elect the fair value option for any of its qualifying financial instruments.
	Fair Value of Financial Instruments
	The Company’s financial instruments consist of cash and cash equivalents, accounts payable and accrued expenses, convertible notes payable, derivative liability, amounts due to related parties and loans payable. The carrying amount of these financial instruments approximates fair value due either to length of maturity or interest rates that approximate prevailing market rates unless otherwise disclosed in these financial statements.
	Income Taxes
	Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized.
	Use of Estimates
	The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.
	Revenue Recognition
	The Company recognizes revenue when products are fully delivered or services have been provided and collection is reasonably assured.
	Foreign Currency
	Until December 1, 2014, the operations of the Company were located in England and Wales. Stragenics maintained a Great Britain Pounds bank account. The functional currency is the U.S. Dollar. Transactions in foreign currencies other than the functional currency, if any, are re-measured into the functional currency at the rate in effect at the time of the transaction. Monetary assets and liabilities denominated in Great Britain Pounds are translated into U.S. Dollars at the rate in effect at the balance sheet date. Revenue and expenses denominated in Great Britain Pounds Dollars are translated at the average exchange rate.
	Basic Income (Loss) Per Share
	Basic income (loss) per share is calculated by dividing the Company’s net loss applicable to common shareholders by the weighted average number of common shares during the period. Diluted earnings per share is calculated by dividing the Company’s net income available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. There are no such common stock equivalents outstanding as of March 31, 2015.
	Stock-Based Compensation
	Stock-based compensation is accounted for at fair value in accordance with ASC Topic 718. To date, the Company has not adopted a stock option plan and has not granted any stock options.
	Recent Accounting Pronouncements
	On June 10, 2014, the Financial Accounting Standards Board ("FASB") issued update ASU 2014-10, Development Stage Entities (Topic 915).   Amongst other things, the amendments in this update removed the definition of development stage entity from Topic 915, thereby removing the distinction between development stage entities and other reporting entities from US GAAP.  In addition, the amendments eliminate the requirements for development stage entities to (1) present inception-to-date information on the statements of income, cash flows and shareholders’ equity, (2) label the financial statements as those of a development stage entity; (3) disclose a description of the development stage activities in which the entity is engaged and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage.  The amendments are effective for annual reporting periods beginning after December 31, 2014 and interim reporting periods beginning after December 15, 2015, however entities are permitted to early adopt for any annual or interim reporting period for which the financial statements have yet to be issued.  The Company has elected to early adopt these amendments and accordingly have not labeled the financial statements as those of a development stage entity and have not presented inception-to-date information on the respective financial statements.
	Stragenics does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position or cash flow other than the pronouncement described above.

Going_Concern

Going Concern	3 Months Ended
	Mar. 31, 2015
Going Concern [Abstract]
GOING CONCERN	NOTE 2 – GOING CONCERN
	The financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company has incurred losses since inception, has an accumulated deficit of $3,890,717 as of March 31, 2015, has negative working capital, and further losses are anticipated in the development of its business raising substantial doubt about the Company’s ability to continue as a going concern. The ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management intends to finance operating costs over the next twelve months with existing cash on hand and loans from directors and or private placement of common stock.

Intellectual_Property

Intellectual Property	3 Months Ended
	Mar. 31, 2015
Intellectual Property [Abstract]
INTELLECTUAL PROPERTY	NOTE 3 – INTELLECTUAL PROPERTY
	On December 1, 2014, the Company acquired BakedAmerican.com, a cannabis information website that provides consumer resource information in cannabis legal states. The acquisition price of $175,000 is amortized over the five year estimated useful life of the website. As of March 31, 2015, $11,892 in accumulated amortization expense has been accrued with a balance of $163,108 projected to be expense until November 30, 2019.

Due_to_Related_Parties

Due to Related Parties	3 Months Ended
	Mar. 31, 2015
Due to Related Parties [Abstract]
DUE TO RELATED PARTIES	NOTE 4 – DUE TO RELATED PARTIES
	During the period ended March 31, 2015 and for the year ended December 31, 2014, the Company received advances from the President of the Company in the net amount of $15,720. During the period ended March 31, 2015, the Company repaid $3,000 of those advances. The advances are non-interest bearing and due on demand.

Promissory_Notes

Promissory Notes	3 Months Ended
	Mar. 31, 2015
Promissory Notes [Abstract]
PROMISSORY NOTES	NOTE 5 – PROMISSORY NOTES
	The Company has amounts due to a former officer of the Company and another company controlled by the former president totaling $431,061 as of March 31, 2015. The loans are unsecured, non-interest bearing and due on demand.
	Effective March 18, 2010, the Company entered into a line of credit agreement with a company owned by a former officer of the Company allowing for borrowings of up to $150,000 bearing interest at 8% per annum. The line of credit is unsecured and all borrowings plus interest are due on demand. The balance on the line of credit as of March 31, 2015 is $50,300.
	On September 10, 2013 and September 24, 2013, the Company signed promissory notes with Capital Nordic Ltd. in the amounts of $3,000 and $5,000. The notes plus interest of $450 and $750 respectively were payable after 4 months. The notes are currently in default. Effective March 31, 2014, these notes, plus the accrued interest were assigned to Neoventive LLC, a shareholder of the Company, by Capital Nordic Ltd., As such the accrued interest was added to the principal balance. The principal balance due is $9,200 as of March 31, 2015 and December 31, 2014.
	During the three months ended March 31, 2015, the Company received a $500 advance from the same shareholder. The amount is unsecured, non-interest bearing and has no specific terms of repayment.
	The Company has an amount due of $30,555 to an unrelated party as of March 31, 2015. The amount is unsecured, non-interest bearing and due on demand.
	The Company has an amount due of $6,000 in advances from an unrelated parties. The advance has no specific terms of repayment, is unsecured and non-interest bearing.

Convertible_Notes_Payable

Convertible Notes Payable	3 Months Ended
	Mar. 31, 2015
Convertible Notes Payable [Abstract]
CONVERTIBLE NOTES PAYABLE	NOTE 6 – CONVERTIBLE NOTES PAYABLE
	(a) On February 22, 2010, the Company issued a $250,000 promissory note to a former officer of the Company. The note bears interest at 10% per annum, is unsecured, and was due on December 31, 2010. The holder may convert, at any time, any amount outstanding into shares of common stock of the Company at a conversion price per share equal to 75% of the average of the closing market price of the Company’s common stock during the five trading days immediately preceding the conversion date.
	The Company was required to classify the conversion feature contained within the convertible debt as a derivative liability. As such, the Company recorded a derivative liability related to the convertible debt equal to the estimated fair value of the conversions feature of $175,081 with an equivalent discount on the convertible debt. The debt was fully accreted as of December 31, 2011. The carrying value of the convertible debt as of March 31, 2015 is $250,000. The derivative liability related to this note is recalculated each reporting period. The derivative liability was $180,516 as of March 31, 2015.
	(b) On April 13, 2010, the Company entered into a $250,000 draw down promissory note agreement with Paramount Trading Company, a non-related party. Amounts drawn on this credit facility bear interest at 8% per annum, are unsecured, and were due on April 13, 2011. Effective March 31, 2014, Paramount Trading Company assigned this note, along with accrued interest to Liberty Resources Ltd., whereby the principal balance of $250,000 and accrued interest of $59,001 were reclassified into a new principal balance of $309,001
	The holder could convert, at any time, any amount outstanding into shares of common stock of the Company at a conversion price per share equal to 75% of the average of the closing market price of the Company’s common stock during the thirty trading days immediately preceding the conversion date. On October 14, 2010, the conversion price was changed to be fixed at $0.45 per share.
	As of March 31, 2015, the outstanding balance is $309,001. The Company was required to classify the conversion feature contained within the convertible debt as a derivative liability. As such, the Company recorded a derivative liability related to the convertible debt equal to the estimated fair value of the conversion feature of $260,265 with an equivalent discount on the convertible debt. Upon modification of the conversion feature, the derivative liability was removed as the number of shares to be issued upon conversion became fixed.
	(c) Effective January 31, 2005, a former officer of the Company entered into a line of credit agreement with a financial institution allowing for borrowings of up to $800,000 with annual interest at prime to be used to fund the operations of the Company. The line of credit is secured by the principal residence of the former President of the Company. Monthly interest-only payments are required. On October 21, 2010, the Company agreed to add a conversion option to the entire balance of principal and interest outstanding at any time on the line of credit. The President of the Company may elect to convert, at any time, any amount outstanding into shares of common stock of the Company at a conversion price per share equal to 75% of the average of the closing market price of the Company’s common stock during the five trading days immediately preceding the conversion date. The maturity date was December 31, 2011 and the note is now due on demand.
	As of March 31, 2015, the outstanding balance is $788,472 (December 31, 2013 - $788,472). The Company was required to classify the conversion feature contained within the convertible debt as a derivative liability. As such, the Company recorded a derivative liability related to the convertible debt equal to the estimated fair value of the conversion feature of $190,274 with an equivalent discount on the convertible debt. The debt was fully accreted as of December 31, 2011.  The carrying value of the convertible debt as of March 31, 2015 is $788,472. The derivative liability related to this note is recalculated each reporting period. The derivative liability was $569,326 as of March 31, 2015.
	(d) Effective March 31, 2014, Laurag Associates S.A., assigned two defaulted notes, plus accrued interest that it held to Neoventive LLC, in the collective amount of $23,250 one dated August 31, 2012 in which the Company issued a 6% convertible note for proceeds of $20,000 and the second dated March 12, 2013 in which the Company issued a 5% promissory note in the amount of $2,500. Upon the effectiveness of the assignment, both notes had interest at 6% and maintained the same conversion features. The holder may elect to convert, at any time, any amount outstanding into shares of common stock of the Company at a conversion price per share equal to the market price of the stock as determined by taking the average trading price of the stock over the previous 30 days.
	The Company was required to classify the conversion feature contained within the convertible debt as a derivative liability. As such, the Company recorded a derivative liability related to the convertible debt equal to the estimated fair value of the conversion feature of $1,407 with an equivalent discount on the convertible debt. The debt was fully accreted as of March 31, 2015.  The carrying value of the convertible debt as of March 31, 2015 is $23,250. The derivative liability related to this note is recalculated each reporting period. The derivative liability was $11,821 as of March 31, 2015. The note is currently in default.
	(e) On November 16, 2012 the Company issued a 6% convertible note for proceeds of $66,709 which matured on November 16, 2013. The holder may elect to convert, at any time, any amount outstanding into shares of common stock of the Company at a conversion price per share equal to the market price of the stock as determined by taking the average trading price of the stock over the previous 30 days. The derivative liability related to this note is recalculated each reporting period.
	The Company was required to classify the conversion feature contained within the convertible debt as a derivative liability. As such, the Company recorded a derivative liability related to the convertible debt equal to the estimated fair value of the conversion feature of $1,410 with an equivalent discount on the convertible debt. The debt was fully accreted as of December 31, 2014. The carrying value of the convertible debt as of December 31, 2014 is $66,709. The derivative liability related to this note was recalculated each reporting period. The note is currently in default.
	On July 1, 2014, the conversion feature of the loan was modified from a variable conversion price to a fixed conversion price of $0.01 per share. As a result of the loan modification, the remaining derivative liability as of July 1, 2014 of $5,121 was recorded as a gain on modification of loan terms. A debt discount of $66,709 to recognize the value of the conversion feature, was recorded on July 1, 2014, which was fully amortized as of December 31, 2014.
	(f) On March 31, 2014, the Company issued a convertible promissory note for $15,000 to Neoventive LLC. The note was due on October 1, 2014, is unsecured and bears interest at 8%. The note and any accrued interest may be converted into shares of the Company’s common stock at fair market value. The Company was required to classify the conversion feature contained within the convertible debt as a derivative liability. As such, the Company recorded a derivative liability related to the convertible debt equal to the estimated fair value of the conversion feature of $9,834 with an equivalent discount on the convertible debt. As of December 31, 2014, the unamortized debt discount was $0. The carrying value of the convertible debt as of December 31, 2014 was $15,000. The derivative liability related to this note is recalculated each reporting period. The same party loaned an additional $5,000 under the same terms of the above loan during the year ended December 31, 2014. The entire balance of $20,000 was repaid during the three months ended March 31, 2015. The accrued interest remains due as of March 31, 2015.
	(g) Effective January 2, 2015, the Company issued an 8% convertible note to KBM Worldwide Inc., for proceeds of $33,000 which matures on September 12, 2015. Among other terms, the holder may elect to convert, at any time after one hundred eighty days (180), any amount outstanding into shares of common stock of the Company at a conversion price per share equal to 51% of the average of the three lowest days closing market prices during the fifteen day trading period immediately preceding the conversion date. The Company was required to classify the conversion feature contained within the convertible debt as a derivative liability. As such, the Company recorded a derivative liability related to the convertible debt equal to the estimated fair value of the conversion feature of $45,531, with a discount on the convertible debt of $33,000 and a derivative expense of $12,531. The debt discount will be amortized over the life of the debt. The remaining discount was $21,049 as of March 31, 2015. The derivative liability related to this note is recalculated each reporting period. The derivative liability was $74,858 as of March 31, 2015.
	(h) Effective January 16, 2015, the Company issued a 10% convertible note to Tangiers Investment Group LLC for proceeds of $44,000 under terms of a borrowing agreement whereby the Company can borrow up to $220,000 within 270 days of execution of the agreement. The Note, with a 10% original issue discount, has interest under the Note of 10% per annum, with the principal and all accrued but unpaid interest due on or about January 16, 2016. The Note is convertible at any time at Tangier’s option into shares of the Company’s common stock at a variable conversion price of 55% of the lowest traded price during the 20 days prior to the notice of conversion, subject to adjustment and other terms as described in the Note.
	The Company was required to classify the conversion feature contained within the convertible debt as a derivative liability. As such, the Company recorded a derivative liability related to the convertible debt equal to the estimated fair value of the conversion feature of $67,262, with a discount on the convertible debt of $44,000 and a derivative expense of $23,262. The debt discount will be amortized over the life of the debt. The remaining discount was $34,251 as of March 31, 2015. The derivative liability related to this note is recalculated each reporting period. The derivative liability was $119,713 as of March 31, 2015.
	(i) On March 6, 2015, the Company issued an 8% convertible note to Vis Vires Group Inc., for proceeds of $33,000 which matures on or about December 7, 2015. Among other terms, the holder may elect to convert, at any time after one hundred eighty days (180), any amount outstanding into shares of common stock of the Company at a conversion price per share equal to 51% of the average of the three lowest days closing market prices during the fifteen day trading period immediately preceding the conversion date.
	The Company was required to classify the conversion feature contained within the convertible debt as a derivative liability. As such, the Company recorded a derivative liability related to the convertible debt equal to the estimated fair value of the conversion feature of $160,997, with a discount on the convertible debt of $33,000 and a derivative expense of $127,997. The debt discount will be amortized over the life of the debt. The remaining discount was $29,676 as of March 31, 2015. The derivative liability related to this note is recalculated each reporting period. The derivative liability was $83,998 as of March 31, 2015.

Common_Stock

Common Stock	3 Months Ended
	Mar. 31, 2015
Common Stock [Abstract]
COMMON STOCK	NOTE 7 – COMMON STOCK
	The Company originally had an unlimited number of shares of no par value common stock.
	On inception, the Company issued 10 shares of common stock at £1.00 per share to its founder for total cash proceeds of £10, which converted at its historical rate is $15. The Company closed a share exchange transaction effective March 23, 2013 with the shareholders of Resource Exchange of America Corp. This share exchange transaction constituted a reverse merger and a recapitalization of Allerayde.  In conjunction with this reverse merger, the historical accounts of Allerayde become the historical accounts of Resource Exchange of America Corp for accounting purposes. The shareholders of Allerayde were issued 75,872,411 shares of Resource Exchange, representing 98.97% of the issued and outstanding shares of Resource Exchange. At the time of the reverse merger there were 786,328 shares of common stock outstanding.
	On January 31, 2013, the Company amended its Articles of Incorporation to increase the total authorized shares of common stock, par value $.0001 per share from 250,000,000 shares to 400,000,000 shares and to additionally authorize a total of 100,000,000 shares of preferred stock, par value $.0001 per share which may be issued by the Company.
	On December 1, 2014, the Company issued 5,000,000 shares of common stock for its acquisition of BakedAmerican.com at a valuation of $175,000. On April 1, 2015, the Company and the seller agreed to amend the purchase terms of the acquisition whereby the stock issued was returned and exchanged for a promissory note with a face value of $175,000. (See Note 10 - Subsequent Events.)
	On December 30, 2014, the Company agreed to issue 4,221,600 shares of common stock for notes payable of $21, 108 plus an agreement to cancel the balance of notes payable and accrued interest in the amount of $59,669.
	On January 16, 2015, the Company agreed to issue 1,618,752 shares of its common stock, at $0.0731 per share as part of a commitment fee under the terms of an Equity Line of Credit Agreement.
	As of March 31, 2015 there were 99,845,602 shares of common stock issued and outstanding.

Commitments_and_Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2015
Commitments and Contingencies [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 8 – COMMITMENTS AND CONTINGENCIES
	The Company had entered into a lease agreement for its business premises, which called for monthly payments in the amount of approximately £368 through May 31, 2014. The lease was assumed by the former CEO upon the change of control on March 4, 2014. The former officers and directors are involved in other business activities and as a result, $1,081 in accrued rent was written off as of March 31, 2015.

Income_Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2015
Income Taxes [Abstract]
INCOME TAXES	NOTE 9 – INCOME TAXES
	As of March 31, 2015, the Company had net operating loss carry forwards of approximately $1,297,266 that may be available to reduce future years’ taxable income arising from the same trade. Future tax benefits, which may arise as a result of these losses, have not been recognized in these financial statements, as their realization is determined not likely to occur and accordingly, the Company has recorded a valuation allowance for the deferred tax asset relating to these tax loss carry-forwards.
	The provision for corporate income tax at the expected rate of 34% consists of the following for the three months ended March 31, 2015 and 2014:
		2015			2014
	Corporate income tax benefit attributable to:
	Current Operations	$	265,271		$	97,989
	Less: valuation allowance		(265,271	)		(97,989	)
	Net provision for Corporate income taxes	$	-		$	-
	The cumulative tax effect at the expected rate of 34% of significant items comprising our net deferred tax amount is as follows as of March 31, 2015 and December 31, 2014:
		March 31, 2015			December 31, 2014
	Deferred tax asset attributable to:
	Net operating loss carryover	$	441,070		$	175,799
	Less: valuation allowance		(441,070	)		(175,799	)
	Net deferred tax asset	$	-		$	-

Subsequent_Events

Subsequent Events	3 Months Ended
	Mar. 31, 2015
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 10 – SUBSEQUENT EVENTS
	In accordance with ASC Topic 855-10, the Company has analyzed its operations subsequent to March 31, 2015 to the date these financial statements were issued, and has determined that it does not have any material subsequent events to disclose in these financial statements other than the events described above.
	On April 1, 2015, the Company and Healthnostics, Inc., the seller of BakedAmerican.com agreed to amend the acquisition agreement between the companies whereby Healthnostics, Inc., would return 5,000,000 shares of the Company’s common stock in exchange for a promissory note payable, due on March 31, 2016 in the amount of $175,000, with an interest rate of 6%.
	On April 2, 2015, the Company issued an 8% convertible note to LG Capital Funding LLC, for proceeds of $63,000 which matures on October 1, 2015. Among other terms, the holder may elect to convert, at any time after one hundred eighty days (180), any amount outstanding into shares of common stock of the Company at a conversion price per share equal to 40% of the average of the lowest trading price with a 20 day look back.
	Effective May 12, 2015, The Company entered into a 10% Convertible Promissory Note and Warrant Agreement with JDF Capital Inc. In accordance with the terms of the Note with JDF Capital Inc., the Company can borrow up to $330,000, of which the Company borrowed $61,600 on January 16, 2015 and with an additional $268,400 available for additional borrowings at JDF’s discretion after the initial $61,600. Each advance principal and interest is due 12 months from the applicable funding date. Warrants, with a term of 5 years, received are equal to 100% of the common stock shares eligible for conversion on the date of the initial funding with an exercise price equal 110% of the initial conversion price. The terms of conversion, among other terms, is equal to 50% of the average of the 3 lowest reported sale prices on the common stock for the 20 trading days immediately prior to the closing date of the financing or 50% of the average of the 3 lowest reported sale prices for the 20 days prior to the conversion date of the Note.
	On April 25, 2015, Tangiers Investment Group LLC converted $25,000 of an assigned portion of the Liberty Resources Ltd., Note it purchased into 375,000 shares of common stock.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2015
Summary of Significant Accounting Policies [Abstract]
Nature of Business	Nature of Business
	Stragenics, Inc., formerly known as Allerayde SAB, Inc. (the “Company” or “Stragenics”) was incorporated under the laws of the State of Florida on January 15, 2009. On February 23, 2010, the Company changed its name to Resource Exchange of America Corp. Effective April 30, 2013, the Company changed its name to Allerayde SAB, Inc. Effective April 28, 2014, the Company changed its name to Stragenics, Inc.
	The Company’s prior business was a mobile enterprise software company aimed at improving productivity of field service organizations. Upon completion of the acquisition of assets from UTP Holdings, LLC on February 22, 2010, the Company adopted the business of UTP Holdings, LLC. The Company was then engaged in the business of recycling ferrous and nonferrous metals to customers in the United States and abroad.
	On March 21, 2013, the Company entered into a Share Exchange Agreement with Allerayde SAB Limited. (“Allerayde”) and Mike Rhodes, the sole member of Allerayde (the “Allerayde Stockholder”) (the “Share Exchange Agreement”). This share exchange transaction constituted a reverse merger and a recapitalization of Stragenics (formerly Allerayde).  In conjunction with this reverse merger, the historical accounts of Stragenics become the historical accounts of Resource Exchange of America Corp for accounting purposes. The Company was then engaged in the business of developing and manufacturing allergy management products in the United Kingdom and other countries such as the U.S. and Canada.
	On March 4, 2014, the Company underwent a change of control and entered into a Termination Agreement (the “Agreement”), whereby Allerayde SAB, Ltd, the Company’s subsidiary reverted to former management effective December 1, 2014, thereby reverting the subsidiary back to former management.
	On December 1, 2014, the Company acquired BakedAmerican.com, and began new operations as an internet-based, social media, marketing and development company.
Accounting Basis	Accounting Basis
	The Company uses the accrual basis of accounting and accounting principles generally accepted in the United States of America (“GAAP” accounting).  The Company has adopted a December 31 fiscal year end.
Cash and Cash Equivalents	Cash and Cash Equivalents
	Stragenics considers all highly liquid investments with maturities of three months or less to be cash equivalents. At March 31, 2015 and December 31, 2014, respectively, the Company had $5,755 and $104 of cash, respectively.
Fair Value Measurements	Fair Value Measurement
	FASB ASC 820, “Fair Value Measurements” defines fair value, establishes a framework for measuring fair value under generally accepted accounting principles and prescribes disclosures about fair value measurements.
	As defined in ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. The Company classifies fair value balances based on the observability of those inputs. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement).
	The three levels of the fair value hierarchy defined by ASC 820 are as follows:
	Level 1 - Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.
	Level 2 - Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date. Level 2 includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.
	Level 3 - Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.
	The valuation techniques that may be used to measure fair value are as follows:
	Market approach - Uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities.
	Income approach - Uses valuation techniques to convert future amounts to a single present amount based on current market expectations about those future amounts, including present value techniques, option-pricing models and excess earnings method.
	Cost approach - Based on the amount that currently would be required to replace the service capacity of an asset (replacement cost).
	The carrying value of the Company’s borrowings is a reasonable estimate of its fair value as borrowings under the Company’s credit facility have variable rates that reflect currently available terms and conditions for similar debt.
	The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment, and may affect the valuation of fair value assets and liabilities and their placement within the fair value hierarchy levels.
	The following table sets forth by level within the fair value hierarchy the Company’s financial assets and liabilities that were accounted for at fair value as of March 31, 2105 and December 31, 2014. As required by FASB ASC 820, financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.
	31-Mar-15	Level I		Level II		Level III		Total
	Derivative liability	$	-	$	1,040,232	$	-	$	1,040,232
	Total liabilities	$	-	$	3,439,295	$	-	$	3,439,295
	31-Dec-14	Level I		Level II		Level III		Total
	Derivative liability	$	-	$	372,286	$	-	$	372,286
	Total liabilities	$	-	$	2,754,996	$	-	$	2,754,996
	In addition, the FASB issued, “The Fair Value Option for Financial Assets and Financial Liabilities. This guidance expands opportunities to use fair value measurements in financial reporting and permits entities to choose to measure many financial instruments and certain other items at fair value. The Company did not elect the fair value option for any of its qualifying financial instruments.
Fair Value of Financial Instruments	Fair Value of Financial Instruments
	The Company’s financial instruments consist of cash and cash equivalents, accounts payable and accrued expenses, convertible notes payable, derivative liability, amounts due to related parties and loans payable. The carrying amount of these financial instruments approximates fair value due either to length of maturity or interest rates that approximate prevailing market rates unless otherwise disclosed in these financial statements.
Income Taxes	Income Taxes
	Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized.
Use of Estimates	Use of Estimates
	The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Revenue Recognition	Revenue Recognition
	The Company recognizes revenue when products are fully delivered or services have been provided and collection is reasonably assured.
Foreign Currency	Foreign Currency
	Until December 1, 2014, the operations of the Company were located in England and Wales. Stragenics maintained a Great Britain Pounds bank account. The functional currency is the U.S. Dollar. Transactions in foreign currencies other than the functional currency, if any, are re-measured into the functional currency at the rate in effect at the time of the transaction. Monetary assets and liabilities denominated in Great Britain Pounds are translated into U.S. Dollars at the rate in effect at the balance sheet date. Revenue and expenses denominated in Great Britain Pounds Dollars are translated at the average exchange rate.
Basic Income (Loss) Per Share	Basic Income (Loss) Per Share
	Basic income (loss) per share is calculated by dividing the Company’s net loss applicable to common shareholders by the weighted average number of common shares during the period. Diluted earnings per share is calculated by dividing the Company’s net income available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. There are no such common stock equivalents outstanding as of March 31, 2015.
Stock-Based Compensation	Stock-Based Compensation
	Stock-based compensation is accounted for at fair value in accordance with ASC Topic 718. To date, the Company has not adopted a stock option plan and has not granted any stock options.
Recent Accounting Pronouncements	Recent Accounting Pronouncements
	On June 10, 2014, the Financial Accounting Standards Board ("FASB") issued update ASU 2014-10, Development Stage Entities (Topic 915).   Amongst other things, the amendments in this update removed the definition of development stage entity from Topic 915, thereby removing the distinction between development stage entities and other reporting entities from US GAAP.  In addition, the amendments eliminate the requirements for development stage entities to (1) present inception-to-date information on the statements of income, cash flows and shareholders’ equity, (2) label the financial statements as those of a development stage entity; (3) disclose a description of the development stage activities in which the entity is engaged and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage.  The amendments are effective for annual reporting periods beginning after December 31, 2014 and interim reporting periods beginning after December 15, 2015, however entities are permitted to early adopt for any annual or interim reporting period for which the financial statements have yet to be issued.  The Company has elected to early adopt these amendments and accordingly have not labeled the financial statements as those of a development stage entity and have not presented inception-to-date information on the respective financial statements.
	Stragenics does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position or cash flow other than the pronouncement described above.

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2015
Summary of Significant Accounting Policies [Abstract]
Schedule of fair value hierarchy Company's financial assets and liabilities
	31-Mar-15	Level I		Level II		Level III		Total
	Derivative liability	$	-	$	1,040,232	$	-	$	1,040,232
	Total liabilities	$	-	$	3,439,295	$	-	$	3,439,295
	31-Dec-14	Level I		Level II		Level III		Total
	Derivative liability	$	-	$	372,286	$	-	$	372,286
	Total liabilities	$	-	$	2,754,996	$	-	$	2,754,996

Income_Taxes_Tables

Income Taxes (Tables)	3 Months Ended
	Mar. 31, 2015
Income Taxes [Abstract]
Summary of provision for corporate income tax		2015			2014
	Corporate income tax benefit attributable to:
	Current Operations	$	265,271		$	97,989
	Less: valuation allowance		(265,271	)		(97,989	)
	Net provision for Corporate income taxes	$	-		$	-
Summary of deferred income tax assets		March 31, 2015			December 31, 2014
	Deferred tax asset attributable to:
	Net operating loss carryover	$	441,070		$	175,799
	Less: valuation allowance		(441,070	)		(175,799	)
	Net deferred tax asset	$	-		$	-

Summary_of_Significant_Account3

Summary of Significant Accounting Policies (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Defined Benefit Plan Disclosure [Line Items]
Derivative liability	$1,040,232	$372,286
Total Liabilities	3,439,295	2,754,996
Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Derivative liability
Total Liabilities
Level II [Member]
Defined Benefit Plan Disclosure [Line Items]
Derivative liability	1,040,232	372,286
Total Liabilities	3,439,295	2,754,996
Level III [Member]
Defined Benefit Plan Disclosure [Line Items]
Derivative liability
Total Liabilities

Summary_of_Significant_Account4

Summary of Significant Accounting Policies (Details Textual) (USD $)	Mar. 31, 2015	Dec. 31, 2014	Mar. 31, 2014	Dec. 31, 2013
Summary of Significant Accounting Policies (Textual)
Cash and equivalents	$5,755	$104	$5,681

Going_Concern_Details

Going Concern (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Going Concern (Textual)
Deficit accumulated during the development stage	($3,890,717)	($3,110,507)

Intellectual_Property_Details

Intellectual Property (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Intellectual Property [Abstract]
Acquisition price	$175,000
Estimated useful life	5 years
Accumulated amortization expense	11,892
Accrued balance	$163,108	$172,027

Due_to_Related_Parties_Details

Due to Related Parties (Details) (President [Member], USD $)	3 Months Ended
	Mar. 31, 2015
President [Member]
Due to Related Parties (Textual)
Repayment of advances	$3,000
Amount due to related party	$15,720

Promissory_Notes_Details

Promissory Notes (Details) (USD $)	3 Months Ended	12 Months Ended	0 Months Ended
	Mar. 31, 2015	Dec. 31, 2014	Mar. 18, 2010	Sep. 24, 2013	Sep. 10, 2013
Promissory Notes (Textual)
Due to unrelated party	$30,555
Loan from unrelated party	6,000
Principal balance due	9,200	9,200
Advance from shareholder	500
Former President [Member]
Promissory Notes (Textual)
Amount due to related party	431,061
Officer [Member]
Promissory Notes (Textual)
Maximum borrowing capacity under line of credit facility			150,000
Line of credit, amount	50,300
Line of credit facility, Interest rate			8.00%
Capital Nordic Ltd [Member]
Promissory Notes (Textual)
Amount due to related party				5,000	3,000
Line of credit, interest				$750	$450

Convertible_Note_Payable_Detai

Convertible Note Payable (Details) (USD $)

3 Months Ended

0 Months Ended

12 Months Ended

0 Months Ended

Mar. 31, 2015

Mar. 31, 2014

Feb. 22, 2010

Apr. 13, 2010

Jan. 31, 2005

Nov. 16, 2012

Dec. 31, 2014

Jan. 02, 2015

Jan. 16, 2015

Mar. 06, 2015

Jul. 01, 2014

Dec. 30, 2014

Mar. 18, 2010

Mar. 12, 2013

Aug. 31, 2012

Oct. 14, 2010

Dec. 31, 2013

Jan. 02, 2015

Convertible Note Payable (Textual)

Derivative liability

$1,040,232

$372,286

Accrued interest

267,546

242,917

59,669

Proceeds from convertible notes payable

110,000

Discount on convertible debt

25,023

1,302

Derivative expense

167,790

Unamortized discount

0

Officer [Member]

Convertible Note Payable (Textual)

Maximum borrowing capacity under line of credit facility

150,000

Neoventive Llc [Member] | Laurag Associates [Member]

Convertible Note Payable (Textual)

Debt instrument, interest rate

5.00%

5.00%

6.00%

Debt instrument, conversion feature, description

The holder may elect to convert, at any time, any amount outstanding into shares of common stock of the Company at a conversion price per share equal to the market price of the stock as determined by taking the average trading price of the stock over the previous 30 days.

Estimated fair value of the conversion feature

1,407

Carrying value of convertible debt

20,000

Derivative liability

11,821

Promissory notes carrrying amount

23,250

2,500

20,000

Convertible Notes Payable [Member] | Officer [Member]

Convertible Note Payable (Textual)

Amount of convertible promissory notes

250,000

Debt instrument, interest rate

10.00%

Maturity date

31-Dec-10

Debt instrument, conversion feature, description

The holder may convert, at any time, any amount outstanding into shares of common stock of the Company at a conversion price per share equal to 75% of the average of the closing market price of the Company's common stock during the five trading days immediately preceding the conversion date.

Estimated fair value of the conversion feature

175,081

Carrying value of convertible debt

250,000

Derivative liability

180,516

Convertible Notes Payable One [Member] | Non - Related Party [Member]

Convertible Note Payable (Textual)

Amount of convertible promissory notes

250,000

Maturity date

13-Apr-11

Debt instrument, conversion feature, description

The holder could convert, at any time, any amount outstanding into shares of common stock of the Company at a conversion price per share equal to 75% of the average of the closing market price of the Company's common stock during the thirty trading days immediately preceding the conversion date.

Estimated fair value of the conversion feature

260,265

Carrying value of convertible debt

309,001

Debt instrument, conversion price

$0.45

Line of credit facility, interest rate

8.00%

Promissory notes carrrying amount

250,000

Accrued interest

59,001

Outstanding convertible debt

309,001

Conversion Price

$0.45

Convertible Notes Payable Two [Member] | Former Officer [Member]

Convertible Note Payable (Textual)

Maturity date

31-Dec-11

Debt instrument, conversion feature, description

Equal to 75% of the average of the closing market price of the Company's common stock during the five trading days immediately preceding the conversion date. The maturity date was December 31, 2011 and the note is now due on demand.

Estimated fair value of the conversion feature

190,274

Carrying value of convertible debt

788,472

Derivative liability

569,326

Outstanding convertible debt

788,472

788,472

Maximum borrowing capacity under line of credit facility

800,000

Convertible Notes Payable Seven [Member]

Convertible Note Payable (Textual)

Debt instrument, interest rate

6.00%

Maturity date

16-Nov-13

Debt instrument, conversion feature, description

The holder may elect to convert, at any time, any amount outstanding into shares of common stock of the Company at a conversion price per share equal to the market price of the stock as determined by taking the average trading price of the stock over the previous 30 days.

Estimated fair value of the conversion feature

1,410

Carrying value of convertible debt

66,709

Proceeds from convertible notes payable

66,709

Convertible Notes Payable Eight [Member] | KBM Worldwide Inc [Member]

Convertible Note Payable (Textual)

Amount of convertible promissory notes

33,000

Debt instrument, interest rate

8.00%

Maturity date

12-Sep-15

Debt instrument, conversion feature, description

The holder may elect to convert, at any time after one hundred eighty days (180), any amount outstanding into shares of common stock of the Company at a conversion price per share equal to 51% of the average of the three lowest days closing market prices during the fifteen day trading period immediately preceding the conversion date.

Estimated fair value of the conversion feature

45,531

Discount on convertible debt

33,000

Derivative expense

12,531

Unamortized discount

21,049

Derivative Liability

74,858

Convertible Notes Payable Nine [Member] | Tangiers Investment Group LLC [Member]

Convertible Note Payable (Textual)

Amount of convertible promissory notes

44,000

Debt instrument, interest rate

10.00%

Debt instrument, conversion feature, description

The Note is convertible at any time at Tangier's option into shares of the Company's common stock at a variable conversion price of 55% of the lowest traded price during the 20 days prior to the notice of conversion, subject to adjustment and other terms as described in the Note.

Estimated fair value of the conversion feature

67,262

Maximum borrowing capacity under line of credit facility

220,000

Debt conversion, original debt, interest rate of debt

10.00%

Discount on convertible debt

44,000

Derivative expense

23,262

Unamortized discount

34,251

Derivative Liability

119,713

Convertible Notes Payable Ten [Member] | Vis Vires Group Inc [Member]

Convertible Note Payable (Textual)

Amount of convertible promissory notes

33,000

Debt instrument, interest rate

8.00%

Maturity date

7-Dec-15

Debt instrument, conversion feature, description

The holder may elect to convert, at any time after one hundred eighty days (180), any amount outstanding into shares of common stock of the Company at a conversion price per share equal to 51% of the average of the three lowest days closing market prices during the fifteen day trading period immediately preceding the conversion date.

Estimated fair value of the conversion feature

160,997

Discount on convertible debt

33,000

Derivative expense

127,997

Unamortized discount

29,676

Derivative Liability

83,998

Convertible Notes Payable Twelve [Member]

Convertible Note Payable (Textual)

Estimated fair value of the conversion feature

66,709

Debt instrument, conversion price

$0.01

Conversion Price

$0.01

Gain on modification of loan

5,121

Convertible Notes Payable Twelve [Member] | Neoventive Llc [Member]

Convertible Note Payable (Textual)

Amount of convertible promissory notes

15,000

Debt instrument, interest rate

8.00%

Maturity date

1-Oct-14

Estimated fair value of the conversion feature

9,834

Carrying value of convertible debt

15,000

Additional borrowings

5,000

Repayment of loan

20,000

Unamortized discount

$0

Common_Stock_Details

Common Stock (Details)	3 Months Ended						0 Months Ended
	Mar. 31, 2015	Mar. 31, 2015	Jan. 16, 2015	Dec. 31, 2014	Dec. 30, 2014	Jan. 31, 2013	Apr. 01, 2015	Jan. 16, 2015	Dec. 30, 2014	Dec. 01, 2014
	USD ($)	EUR (€)	USD ($)	USD ($)	USD ($)	USD ($)	Subsequent Event [Member]	Common Stock [Member]	Common Stock [Member]	Common Stock [Member]
							USD ($)			USD ($)
Common Stock (Textual)
Share issued on inception	10	10
Issue price per share		€ 1
Stock historical rate	$15
Stock issued to stockholders pursuant to recapitalization of Allerayde	75,872,411	75,872,411
Percentage of equity issued	98.97%	98.97%
Merger/recapitalization, shares	786,328	786,328
Common stock authorized	400,000,000	400,000,000				400,000,000
Common stock shares authorized prior to amendment						250,000,000
Common stock, Par value	$0.00		$0.07			$0.00
Additional authorized preferred capital						100,000,000
Preferred Stock, par value per share						$0.00
Common stock, Shares issued	99,845,602	99,845,602		98,226,850
Common stock, Shares outstanding	99,845,602	99,845,602		98,226,850
Record conversion of note payable and forgiveness of remaining balance, shares								1,618,752	4,221,600
Accrued interest	$267,546			$242,917	$59,669
Business combination purchase							175,000
Common stock issued for acquisition, value	$175,000									$175,000
Common stock issued for acquisition, Share										5,000,000

Commitments_and_Contingencies_

Commitments and Contingencies (Details)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2015
	EUR (€)	Director [Member]
		USD ($)
Commitments and Contingencies (Textual)
Lease expiration date	31-May-14
Monthly payment of leased premises	€ 368
Accrued rent		$1,081

Income_Taxes_Details

Income Taxes (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Corporate income tax benefit attributable to:
Current operations	$265,271	$97,989
Less: valuation allowance	-265,271	-97,989
Net provision for Corporate income taxes

Income_Taxes_Details_1

Income Taxes (Details 1) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Deferred tax asset attributable to:
Net operating loss carryover	$441,070	$175,799
Less: valuation allowance	-441,070	-175,799
Net deferred tax asset

Income_Taxes_Details_Textual

Income Taxes (Details Textual) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Income Taxes (Textual)
Net operating loss carry forwards	$1,297,266
Provision for corporate income tax, expected rate	34.00%	34.00%
Cumulative tax effect, expected rate	34.00%	34.00%

Subsequent_Events_Details

Subsequent Events (Details) (USD $)	3 Months Ended		0 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Apr. 01, 2015	Apr. 02, 2015	Apr. 25, 2015	12-May-15	Dec. 31, 2014	Jan. 16, 2015
Subsequent Event [Line Items]
Common stock, shares issued	99,845,602						98,226,850
Proceeds from convertible note	$110,000
JDF Capital Inc.[Member] | Convertible Promissory Note [Member] | Warrant Agreement [Member]
Subsequent Event [Line Items]
Borrowings								61,600
Subsequent Event [Member]
Subsequent Event [Line Items]
Business combination purchase			175,000
Subsequent Event [Member] | Baked American.Com [Member]
Subsequent Event [Line Items]
Business combination purchase			175,000
Common stock, shares issued			5,000,000
Interest Rate			6.00%
Convertible debt maturity date			31-Mar-16
Subsequent Event [Member] | LG Capital Funding LLC [Member]
Subsequent Event [Line Items]
Conversion Percentage				8.00%
Proceeds from convertible note				63,000
Convertible debt maturity date				1-Oct-15
Convertible debt maturity date description				The holder may elect to convert, at any time after one hundred eighty days (180), any amount outstanding into shares of common stock of the Company at a conversion price per share equal to 40% of the average of the lowest trading price with a 20 day look back.
Subsequent Event [Member] | Tangiers Investment Group LLC [Member]
Subsequent Event [Line Items]
Conversion of common stock, Shares					375,000
Conversion of common stock, Amount					25,000
Subsequent Event [Member] | JDF Capital Inc.[Member] | Convertible Promissory Note [Member] | Warrant Agreement [Member]
Subsequent Event [Line Items]
Convertible debt, description						Each advance principal and interest is due 12 months from the applicable funding date. Warrants, with a term of 5 years, received are equal to 100% of the common stock shares eligible for conversion on the date of the initial funding with an exercise price equal 110% of the initial conversion price. The terms of conversion, among other terms, is equal to 50% of the average of the 3 lowest reported sale prices on the common stock for the 20 trading days immediately prior to the closing date of the financing or 50% of the average of the 3 lowest reported sale prices for the 20 days prior to the conversion date of the Note.
Debt instrument, interest rate						10.00%
Maximum borrowing capacity under line of credit facility						330,000
Additional borrowings						$268,400
Term of warrant						5 years